Shin Yup Lee Selected Research

TP protocol

1/2020	Polymorphisms in Glycolysis-Related Genes Are Associated with Clinical Outcomes of Paclitaxel-Cisplatin Chemotherapy in Non-Small Cell Lung Cancer.
3/2016	A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.
1/2016	PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy.
11/2013	Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shin Yup Lee Research Topics

Disease

28	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 08/2009
26	Neoplasms (Cancer) 04/2022 - 08/2009
15	Lung Neoplasms (Lung Cancer) 03/2022 - 08/2009
10	Pleural Effusion (Pleural Effusions) 01/2022 - 10/2015
4	Malignant Pleural Effusion 01/2022 - 01/2016
4	Adenocarcinoma of Lung 11/2021 - 01/2021
4	Tuberculosis (Tuberculoses) 05/2015 - 04/2013
4	Infections 05/2015 - 04/2013
3	Carcinogenesis 04/2022 - 01/2014
2	Brain Neoplasms (Brain Tumor) 12/2021 - 12/2021
2	Adenocarcinoma 01/2021 - 01/2020
2	COVID-19 09/2020 - 01/2020
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 03/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2019
2	Respiratory Insufficiency (Respiratory Failure) 05/2018 - 06/2014
2	Miliary Tuberculosis 05/2018 - 04/2014
1	Schmid-Fraccaro syndrome 07/2021
1	Lymphatic Metastasis 01/2021
1	Critical Illness (Critically Ill) 09/2020
1	Lymphoma (Lymphomas) 08/2019
1	Chronic Disease (Chronic Diseases) 05/2018
1	Lipid Pneumonia 04/2018
1	Dyspnea (Shortness of Breath) 06/2014
1	Genomic Instability 04/2014
1	Lymphopenia (Lymphocytopenia) 04/2013
1	Hypoalbuminemia 04/2013
1	Pneumonia (Pneumonitis) 01/2013
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2012

Drug/Important Bio-Agent (IBA)

10	ErbB Receptors (EGF Receptor)IBA 04/2022 - 11/2010
8	Adenosine DeaminaseIBA 01/2022 - 10/2015
6	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2013
5	Tyrosine Kinase InhibitorsIBA 03/2022 - 01/2021
5	AfatinibIBA 03/2022 - 01/2021
5	Messenger RNA (mRNA)IBA 01/2020 - 03/2016
4	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2021
4	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021 - 01/2017
4	CytokinesIBA 01/2020 - 04/2013
3	Biomarkers (Surrogate Marker)IBA 03/2021 - 05/2015
3	InterferonsIBA 07/2014 - 04/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022 - 11/2016
2	osimertinibIBA 12/2021 - 01/2021
2	LigandsIBA 08/2021 - 01/2021
2	AntibodiesIBA 08/2021 - 03/2021
2	ChemokinesIBA 07/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 03/2021 - 11/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2015
2	dinophysistoxin 1IBA 01/2020 - 10/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2017
2	C-Reactive ProteinIBA 01/2017 - 04/2013
2	Co-Repressor ProteinsIBA 10/2016 - 11/2014
2	GoldIBA 05/2015 - 04/2014
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Histones (Histone)IBA 11/2021
1	B7-H1 AntigenIBA 11/2021
1	NivolumabIBA 08/2021
1	pembrolizumabIBA 08/2021
1	PlatinumIBA 08/2021
1	Butyrates (Butyrate)IBA 07/2021
1	Epithelial Cell Adhesion MoleculeIBA 03/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2021
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 03/2021
1	Circulating Tumor DNAIBA 01/2021
1	Activating Transcription Factor 3IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	6- trimethylsilylthio- 9- trimethylsilylpurineIBA 01/2021
1	cobicistat mixture with darunavirIBA 09/2020
1	CarbonIBA 01/2020
1	Carcinoembryonic AntigenIBA 01/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019
1	NADP (NADPH)IBA 01/2019
1	AlbuminsIBA 05/2018
1	Hemoglobins (Hemoglobin)IBA 05/2018
1	LipidsIBA 04/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2017
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2015
1	AntigensIBA 05/2015
1	Macrophage Colony-Stimulating FactorIBA 11/2014
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Interleukin-1 Receptor-Associated KinasesIBA 01/2014
1	AcidsIBA 04/2013
1	Immunomodulating AgentsIBA 01/2013
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2012

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 08/2021 - 03/2006
8	Therapeutics 04/2022 - 07/2013
4	TP protocol 01/2020 - 11/2013
2	Radiotherapy 11/2021 - 01/2021
2	Ligation 01/2021 - 03/2016
1	Immunotherapy 04/2022
1	Time-to-Treatment 01/2022
1	Drug Tapering 12/2021
1	Adjuvant Chemotherapy 01/2021
1	Critical Care (Surgical Intensive Care) 01/2020
1	Ketogenic Diet 01/2019
1	Aftercare (After-Treatment) 05/2015
1	Length of Stay 06/2014